Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cell nucleus
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
====PML-nuclear bodies==== [[Promyelocytic leukemia protein]] (PML-nuclear bodies) are spherical bodies found scattered throughout the nucleoplasm, measuring around 0.1β1.0 ΞΌm. They are known by a number of other names, including nuclear domain 10 (ND10), Kremer bodies, and PML oncogenic domains.<ref name="Zimber">{{cite journal | vauthors = Zimber A, Nguyen QD, Gespach C | title = Nuclear bodies and compartments: functional roles and cellular signalling in health and disease | journal = Cellular Signalling | volume = 16 | issue = 10 | pages = 1085β104 | date = October 2004 | pmid = 15240004 | doi = 10.1016/j.cellsig.2004.03.020 | department = Review }}</ref> PML-nuclear bodies are named after one of their major components, the promyelocytic leukemia protein (PML). They are often seen in the nucleus in association with Cajal bodies and cleavage bodies.<ref name="Dundr"/> Pml-/- mice, which are unable to create PML-nuclear bodies, develop normally without obvious ill effects, showing that PML-nuclear bodies are not required for most essential biological processes.<ref name="Lallemand2010">{{cite journal | vauthors = Lallemand-Breitenbach V, de ThΓ© H | title = PML nuclear bodies | journal = Cold Spring Harbor Perspectives in Biology | volume = 2 | issue = 5 | pages = a000661 | date = May 2010 | pmid = 20452955 | pmc = 2857171 | doi = 10.1101/cshperspect.a000661 | department = Review }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)